SCHEMBL6134010

SCHEMBL6134010

COC(=O)c1ccc(-c2ccc(N3CCCN(C4CCCCC4)CC3)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
L3MBTL3 Q96JM7 3/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
MBTD1 Q05BQ5 1/20 0.47
TP53BP1 Q12888 1/20 0.47
L3MBTL4 Q8NA19 1/20 0.47
HRH3 Q9Y5N1 4/20 0.46
ATM Q13315 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
ESR1 P03372 1/20 0.46
ESR2 Q92731 1/20 0.46
HPGD P15428 1/20 0.44
KDM4E B2RXH2 3/20 0.43
TDP1 Q9NUW8 1/20 0.43
OPRL1 P41146 1/20 0.43
FGFR1 P11362 1/20 0.42
FLT1 P17948 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7317032 0.96 ALDH1A1 (0.52) ALDH1A1MEN1KMT2AL3MBTL3L3MBTL1
SCHEMBL6132410 0.89 MEN1 (0.49) ALDH1A1MEN1KMT2AL3MBTL3L3MBTL1
SCHEMBL6132406 0.89 MEN1 (0.49) ALDH1A1MEN1KMT2AL3MBTL3L3MBTL1
SCHEMBL6134631 0.87 HDAC3 (0.50) ALDH1A1MEN1KMT2AL3MBTL3L3MBTL1
SCHEMBL6134442 0.85 HRH3 (0.55) ALDH1A1MEN1KMT2AHRH3ESR1
SCHEMBL6134695 0.85 KMT2A (0.53) ALDH1A1MEN1KMT2AL3MBTL3L3MBTL1
SCHEMBL6134606 0.85 KMT2A (0.53) ALDH1A1MEN1KMT2AL3MBTL3L3MBTL1
SCHEMBL6134608 0.85 KMT2A (0.53) ALDH1A1MEN1KMT2AL3MBTL3L3MBTL1
SCHEMBL6134989 0.85 ALDH1A1 (0.51) ALDH1A1MEN1KMT2AL3MBTL3L3MBTL1
SCHEMBL6135887 0.85 L3MBTL3 (0.51) ALDH1A1MEN1KMT2AL3MBTL3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261177-A1 Compound ASTELLAS PHARMA INC. (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261177-A1 Compound MANBA, MAN2B1, MAN2A1 ALDH1A1 3841/4885MEN1 880/4885KMT2A 4492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.